Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.33M Sell
389,125
-260,925
-40% -$4.65M 0.08% 230
2026
Q1
$12.4M Buy
650,050
+288,787
+80% +$5.58M 0.18% 133
2025
Q4
$5.91M Sell
361,263
-406,814
-53% -$7.16M 0.08% 230
2025
Q3
$14.4M Buy
768,077
+77,407
+11% +$1.39M 0.22% 113
2025
Q2
$14M Buy
690,670
+646,062
+1,448% +$11.2M 0.23% 104
2025
Q1
$613K Sell
44,608
-420,126
-90% -$5.78M 0.01% 795
2024
Q4
$5.51M Buy
+464,734
New +$7.31M 0.1% 217
2024
Q2
Sell
-358,921
Closed -$9.21M 1349
2024
Q1
$9.21M Buy
358,921
+38,671
+12% +$970K 0.18% 147
2023
Q4
$8.35M Sell
320,250
-8,637
-3% -$197K 0.17% 148
2023
Q3
$7.34M Buy
328,887
+319,186
+3,290% +$8M 0.17% 154
2023
Q2
$256K Buy
+9,701
New +$165K 0.01% 1137

Other funds holding XP

Crossmark Global Holdings's XP Position: Q2 2026 in Review

Crossmark Global Holdings reduced its XP (XP) stake by 40% in Q2 2026, selling an estimated $4.65M and leaving 389,125 shares worth $6.33M. The position accounts for 0.08% of the portfolio, ranked #230.

Crossmark Global Holdings first reported a position in XP in Q2 2023 and has held it in 11 quarters since. The position peaked at $14.4M in Q3 2025. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Crossmark Global Holdings held 389,125 shares of XP worth $6.33M as of Q2 2026.
  • Crossmark Global Holdings sold 260,925 XP shares in Q2 2026, an estimated $4.65M.
  • XP made up 0.08% of Crossmark Global Holdings's portfolio in Q2 2026, its #230 holding.
  • Crossmark Global Holdings first reported a position in XP in Q2 2023 and has held it in 11 quarters since.
  • Crossmark Global Holdings's XP position peaked at $14.4M in Q3 2025.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.